Japanese pharmaceutical company headquartered in Osaka (renamed Sumitomo Pharma in 2022), developing and manufacturing prescription medicines in psychiatry and neurology, oncology and regenerative medicine for Japan, North America and Asia.
No hay comentarios disponibles.
Deja tu valoración & comentario